Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MDxHealth SA - Ordinary Shares
(NQ:
MDXH
)
2.595
-0.105 (-3.89%)
Streaming Delayed Price
Updated: 11:33 AM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about MDxHealth SA - Ordinary Shares
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
March 16, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
February 12, 2026
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
January 12, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
January 06, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
November 12, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
November 03, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
September 15, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
August 05, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
July 03, 2025
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Q1-2025 Results
May 14, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
April 30, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
February 26, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
February 12, 2025
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance
January 13, 2025
From
mdxhealth
Via
GlobeNewswire
MDxHealth to Participate in Piper Sandler Healthcare Conference
November 25, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
November 06, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6
October 14, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Announces Pricing of Offering of Ordinary Shares
September 25, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Announces Launch of Offering of Ordinary Shares
September 25, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Q2 and Half Year 2024 Results
August 21, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
August 12, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
July 08, 2024
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
July 08, 2024
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Present at Upcoming Investor Conferences
May 15, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
May 01, 2024
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
March 12, 2024
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
March 06, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6
February 21, 2024
From
mdxhealth
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
